CDH1 and prostate cancer: To determine whether this relationship between NKX3.1 loss and inflammation occurs in human prostate cancer, we performed immunohistochemistry on human prostatectomy samples (n=11) to detect expression of NKX3.1 or E-cadherin, an epithelial cell marker.